Biostime to make equity-linked debut with $322m CB

By Rev Hui
14 Jan 2014

Babycare products manufacturer Biostime International Holdings is in the market for HK$2.5bn ($322m) after launching a zero coupon convertible bond on January 14, its debut in equity-linked.

The five year non put three paper is being offered to investors at a yield to put maturity of 1.875%-2.875% and a conversion premium of 27.5% to 40% over the stock’s reference share price of HK$71.25.

Biostime is currently trading at a record high, having nearly tripled from ...

Already a subscriber?

Continue reading this article

Try full access to GlobalCapital

Free trial